Study of Cytokines in Children With Opsoclonus-Myoclonus Syndrome

Completed

Conditions studied: Opsoclonus-myoclonus Syndrome

In brief

The purpose of this study is to determine if cytokines, inflammatory mediators, are increased in spinal fluid and blood, correlate with disease activity, and could serve as biomarkers or therapeutic targets in children with opsoclonus-myoclonus syndrome (OMS), an autoimmune complication of the tumor neuroblastoma.

Key facts

Study ID

NCT00806182

Run by

National Pediatric Neuroinflammation Organization, Inc.

People needed

400

Starts

2008-01-01

Expected to finish

2016-12-01

Last updated by the study team

2017-05-23

Who can join

Age: 1 and older, up to 18. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Clinical diagnosis of OMS

You may not qualify if…

• Equivocal diagnosis
• Contraindications to lumbar puncture
• Treatment with agents outside the scope of the study

Where it is running

• National Pediatric Myoclonus Center, Formerly at Dept. of Neurology, Southern Illinois University School of Medicine — Springfield, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.